Results 141 to 150 of about 13,103,023 (178)

Long-Term Outcomes of Hepatitis B Virus-Related Cirrhosis Treated With Nucleos(t)Ide Analogs

open access: yesJournal of the Formosan Medical Association, 2017
This study aimed to evaluate the outcomes of chronic hepatitis B patients with cirrhosis who received long-term nucleos(t)ide analog therapy. Methods: A total of 546 consecutive cirrhotic patients treated with entecavir (n = 359), telbivudine (n = 104 ...
Chuan-Mo Lee   +2 more
exaly   +6 more sources

Current Practice and Contrasting Views on Discontinuation of Nucleos(t)Ide Analog Therapy in Chronic Hepatitis B

open access: yesExpert Review of Gastroenterology and Hepatology, 2020
Introduction: Long-term, even indefinite treatment with nucleos(t)ide analogs (NAs) is the current first-line therapy for patients with chronic hepatitis B (CHB), regardless of its histological stage. Guidelines and recommendations on duration and endpoints of NA therapy in CHB are not identical and change over time.Areas covered: The authors review NA
Emilia Hadziyannis   +1 more
exaly   +4 more sources

Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

Clinics in Liver Disease, 2023
In treatment-naïve patients with chronic hepatitis B virus (HBV) infection, entecavir (ETV), tenofovir disoproxil fumarate (TDF), and tenofovir alafenamide have a minimal or no risk of drug-resistance. These 3 nucleos(t)ide analog agents are highly potent inducing high rate of virologic response (reducing serum HBV DNA to levels undetectable by ...
Jonggi, Choi   +2 more
openaire   +2 more sources

Microbial Biosynthesis of Nucleos(t)Ide Analogs: Applications, and Engineering Optimization

Critical Reviews in Microbiology
Nucleos(t)ide analogs constitute a diverse group of compounds derived from nucleosides and nucleotides, playing a crucial role in various biological processes. These analogs exhibit a wide range of applications, including their use as additives, antiviral, and anticancer agents, which makes them valuable in food and medical research. In this review, we
Wenbin Yu
exaly   +3 more sources

Considerations for the Long-Term Treatment of Chronic Hepatitis B With Nucleos(t)Ide Analogs

Expert Review of Gastroenterology and Hepatology, 2012
Treatment of chronic hepatitis B (CHB) with nucleos(t)ide analogs is often required over a prolonged period to achieve durable virologic suppression. One barrier to the success of long-term therapy is the emergence of drug-resistant mutants. Current guidelines therefore recommend the most potent drugs with optimal resistance profiles, that is ...
Maria Buti, Jörg Petersen
exaly   +3 more sources

Three‐year efficacy and safety of tenofovir in nucleos(t)ide analog‐naïve and nucleos(t)ide analog‐experienced chronic hepatitis B patients

Journal of Gastroenterology and Hepatology, 2016
AbstractBackground and Aims:This study compared the efficacy and safety of tenofovir disoproxil fumarate (TDF) up to 3 years of innucleos(t)ide analog (NA)‐naïve and NA‐experienced chronic hepatitis B (CHB) patients.Methods:Tenofovir disoproxil fumarate‐treated NA‐naïve and NA‐experienced CHB patients were retrospectively analyzed.Results:After 3 years
Hsin-Ming, Wang   +10 more
openaire   +2 more sources

Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B

Journal of Hepatology, 2009
The development of clevudine as a treatment for hepatitis B was terminated recently because of case reports of myopathy. In each case, the onset of symptoms occurred between 8 and 13 months after the initiation of treatment. Electromyography and muscle biopsy confirmed the presence of myonecrosis.
Russell D, Fleischer, Anna S F, Lok
openaire   +2 more sources

Impact of Antiviral Therapy With Nucleos(t)Ide Analog on Survival of Patients With HBV-Related Small Hepatocellular Carcinomas

open access: yesCancer Management and Research, 2019
Hepatocellular carcinoma (HCC) is the second leading causes of cancer-related death. HCC is usually based on chronic liver disease, mainly including chronic hepatitis C virus infection or chronic hepatitis B virus (HBV) infection.The objective of the study was to evaluate the impact of the nucleos(t)ide analog (NA) use on the prognosis of patients with
Wei Zhao, Yanyan Wei, Yongxiang Yi
exaly   +5 more sources

Home - About - Disclaimer - Privacy